ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32342-5mg |
|
141237-50-5 |
HIV-1 Rev 34-50 (HIV-1 rev Protein (34-50))
|
0 | C97H173N51O24 | |
GC32342-1mg |
|
141237-50-5 |
HIV-1 Rev 34-50 (HIV-1 rev Protein (34-50))
|
0 | C97H173N51O24 | |
GC32342-500μg |
|
141237-50-5 |
HIV-1 Rev 34-50 (HIV-1 rev Protein (34-50))
|
0 | C97H173N51O24 | |
GC32341-5mg |
|
67700-30-5 |
Furaprofen (R803)
|
0 | C17H14O3 | |
GC32340-10mg |
|
3886-39-3 |
RD3-0028
|
0 | C8H8S2 | |
GC32340-5mg |
|
3886-39-3 |
RD3-0028
|
0 | C8H8S2 | |
GC32340-1mg |
|
3886-39-3 |
RD3-0028
|
0 | C8H8S2 | |
GC32339-5mg |
|
1337482-15-1 |
Sofosbuvir impurity G
|
0 | C22H29FN3O9P | |
GC32339-1mg |
|
1337482-15-1 |
Sofosbuvir impurity G
|
0 | C22H29FN3O9P | |
GC32339-10mM(1mLinDMSO) |
|
1337482-15-1 |
Sofosbuvir impurity G
|
0 | C22H29FN3O9P | |
GC32338-100mg |
|
59-49-4 |
2-Benzoxazolinone (2-Benzoxazolone)
|
0 | C7H5NO2 | |
GC32335-10mg |
|
1610056-01-3 |
Peptide T TFA
|
0 | C37H56F3N9O18 | |
GC32335-5mg |
|
1610056-01-3 |
Peptide T TFA
|
0 | C37H56F3N9O18 | |
GC32335-1mg |
|
1610056-01-3 |
Peptide T TFA
|
0 | C37H56F3N9O18 | |
GC32334-10mg |
|
119474-55-4 |
KB-5246
|
0 | C18H17ClFN3O4S | |
GC32334-5mg |
|
119474-55-4 |
KB-5246
|
0 | C18H17ClFN3O4S | |
GC32334-1mg |
|
119474-55-4 |
KB-5246
|
0 | C18H17ClFN3O4S | |
GC32333-1g |
|
66304-01-6 |
Beaucage reagent
|
0 | C7H4O3S2 | |
GC32333-250mg |
|
66304-01-6 |
Beaucage reagent
|
0 | C7H4O3S2 | |
GC32333-10mM(1mLinDMSO) |
|
66304-01-6 |
Beaucage reagent
|
0 | C7H4O3S2 | |